Announcements Trials
Browse Landscape

Status

Recruiting 28Unknown 22Completed 16Not yet recruiting 9Active not recruiting 9Terminated 5Withdrawn 3Enrolling by invitation 3Suspended 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Breast 3Thoracic 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 33Breast Neoplasms 33Lung Neoplasms 17Colorectal Neoplasms 15Prostatic Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Hematologic Neoplasms 12Carcinoma, Hepatocellular 12Stomach Neoplasms 11Pancreatic Neoplasms 11Diabetes Mellitus 9Melanoma 7Disease 7Colonic Neoplasms 7Pulmonary Disease, Chronic Obstructive 6Cardiovascular Diseases 6Barrett Esophagus 6Urinary Bladder Neoplasms 5Rectal Neoplasms 5Liver Neoplasms 5Leukemia, Myeloid, Acute 5Fatigue 5Uterine Cervical Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pheochromocytoma 4Myasthenia Gravis 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma 4Lymphatic Metastasis 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × Triple Negative Breast Neoplasms × Clear all
NCT06885424 2026-05-20

DESCENT-1

A2 Biotherapeutics Inc.

Enrolling by invitation
400 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06646263 2024-10-17

Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies

Institute of Applied Biosciences

Enrolling by invitation
150 enrolled
Breast

Triple Negative Breast Neoplasms

NCT06409221 2024-05-10

VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study

Concr

Enrolling by invitation
200 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡